AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENTInvestors’ Rights Agreement • August 30th, 2017 • Apellis Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware
THIS AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT is made as of the 7th day of August, 2017, by and among Apellis Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and each of the investors listed on Schedule A hereto, each of which is referred to in this Agreement as an “Investor”, and each of the stockholders listed on Schedule B hereto, each of whom is referred to herein as a “Key Holder” and any additional Investor that becomes a party to this Agreement in accordance with Section 6.9 hereof.
VOTING AGREEMENTVoting Agreement • August 30th, 2017 • Apellis Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware
This is a Voting Agreement (this “Agreement”), dated as of September 8, 2015 between Apellis Pharmaceuticals, Inc., a Delaware corporation (“Apellis”), and Potentia Pharmaceuticals, Inc., a Delaware corporation (“Potentia”).
LEASE BETWEEN APELLIS PHARMACEUTICALS, INC. AS TENANT AND NWALP PHOP PROPERTY OWNER LLC, AS LANDLORD 200 Fifth Avenue, Waltham, MassachusettsLease Agreement • August 30th, 2017 • Apellis Pharmaceuticals, Inc. • Pharmaceutical preparations
THIS LEASE is dated as of April 27, 2017 between the Landlord and the Tenant named below, and is of space in the Building described below.
